Literature DB >> 21377430

Comparison of plasma and dry blood spots as samples for the determination of nitisinone (NTBC) by high-performance liquid chromatography-tandem mass spectrometry. Study of the stability of the samples at different temperatures.

José A Prieto1, Fernando Andrade, Sergio Lage, Luís Aldámiz-Echevarría.   

Abstract

UNLABELLED: Tyrosinemia is an inborn error of metabolism characterized by the accumulation of tyrosine as well as toxic by-products. NTBC or nitisinone is a drug currently used for the treatment of tyrosinemia that avoids the formation of these toxic substances. This paper presents the determination of NTBC in plasma and dry blood spots by high-performance liquid chromatography (HPLC) coupled to tandem mass spectrometry. The concentration of NTBC in matched plasma-dry blood spots was compared and the study of degradation of NTBC in plasma and dry spots at different temperatures is presented.
METHOD: For sample preparation, plasma proteins were precipitated with acetonitrile and 3-mm discs were extracted with methanol. ESI(+) was used as inozation method and the analytes were detected by multiple reaction monitoring using the transitions 330>218 for NTBC and 340>228 for mesotrione, used as internal standard.
RESULTS: There is good correlation between concentrations obtained in dry blood spots and plasma (r(2)=0.83), although values are 2.4 times higher in plasma samples. NTBC in plasma is stable at least for 45 days frozen at -30°C and refrigerated at 4°C. However, it shows slow decomposition at room temperature, approximately 30% after 45 days. The method shows good precision, accuracy and linearity and the detection limit is 50 nmol/L and paper samples are appropriate for the monitorization of NTBC.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21377430     DOI: 10.1016/j.jchromb.2011.01.031

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  8 in total

1.  Single dose NTBC-treatment of hereditary tyrosinemia type I.

Authors:  A Schlune; E Thimm; D Herebian; U Spiekerkoetter
Journal:  J Inherit Metab Dis       Date:  2012-02-04       Impact factor: 4.982

2.  Treatment adherence in tyrosinemia type 1 patients.

Authors:  Domingo González-Lamuño; Paula Sánchez-Pintos; Fernando Andrade; María L Couce; Luís Aldámiz-Echevarría
Journal:  Orphanet J Rare Dis       Date:  2021-06-03       Impact factor: 4.123

3.  A Stability Indicating HPLC Method for the Determination of Nitisinone in Capsules.

Authors:  Effat Souri; Farnaz R Lahiji; Tannaz Nourhashemi; H Jalalizadeh
Journal:  Indian J Pharm Sci       Date:  2015 May-Jun       Impact factor: 0.975

Review 4.  Use of Dried Blood Spot Specimens to Monitor Patients with Inherited Metabolic Disorders.

Authors:  Stuart J Moat; Roanna S George; Rachel S Carling
Journal:  Int J Neonatal Screen       Date:  2020-03-26

5.  β-Cyclodextrin Derivative Grafted on Silica Gel Represents a New Polymeric Sorbent for Extracting Nitisinone from Model Physiological Fluids.

Authors:  Magdalena Danek; Anna Korytkowska-Wałach; Hanna Barchańska
Journal:  Molecules       Date:  2021-09-30       Impact factor: 4.411

6.  Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice.

Authors:  Sebene Mayorandan; Uta Meyer; Gülden Gokcay; Nuria Garcia Segarra; Hélène Ogier de Baulny; Francjan van Spronsen; Jiri Zeman; Corinne de Laet; Ute Spiekerkoetter; Eva Thimm; Arianna Maiorana; Carlo Dionisi-Vici; Dorothea Moeslinger; Michaela Brunner-Krainz; Amelie Sophia Lotz-Havla; José Angel Cocho de Juan; Maria Luz Couce Pico; René Santer; Sabine Scholl-Bürgi; Hanna Mandel; Yngve Thomas Bliksrud; Peter Freisinger; Luis Jose Aldamiz-Echevarria; Michel Hochuli; Matthias Gautschi; Jessica Endig; Jens Jordan; Patrick McKiernan; Stefanie Ernst; Susanne Morlot; Arndt Vogel; Johannes Sander; Anibh Martin Das
Journal:  Orphanet J Rare Dis       Date:  2014-08-01       Impact factor: 4.123

7.  Inter-laboratory analytical improvement of succinylacetone and nitisinone quantification from dried blood spot samples.

Authors:  Hilde Laeremans; Charles Turner; Tommy Andersson; Jose Angel Cocho de Juan; Adam Gerrard; M Rebecca Heiner-Fokkema; Diran Herebian; Nils Janzen; Giancarlo la Marca; Mattias Rudebeck
Journal:  JIMD Rep       Date:  2020-04-04

8.  NTBC Treatment Monitoring in Chilean Patients with Tyrosinemia Type 1 and Its Association with Biochemical Parameters and Liver Biomarkers.

Authors:  Karen Fuenzalida; María Jesús Leal-Witt; Patricio Guerrero; Valerie Hamilton; María Florencia Salazar; Felipe Peñaloza; Carolina Arias; Verónica Cornejo
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.